Clinical Trial Detail

NCT ID NCT01810913
Title Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Radiation Therapy Oncology Group
Indications

head and neck squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma

Therapies

Docetaxel

Cisplatin

Cetuximab + Docetaxel

Age Groups: adult

No variant requirements are available.